Adil Daud


Oncologist and melanoma specialist
Immunotherapy researcher, history and literature buff

Dr. Adil Daud, an oncologist, specializes in melanoma and other skin cancers. He is co-director of the Melanoma Center. In addition to caring for patients, he directs research to better understand the biology of melanoma and to develop new treatments. He has developed and led many clinical trials that have expanded the use of gene therapy for melanoma.

Daud earned a medical degree at the Government Medical College, Nagpur. He completed both an internship and a residency in internal medicine at Indiana University School of Medicine, followed by a fellowship in hematology-oncology at Memorial Sloan Kettering Cancer Center. Prior to joining UCSF Medical Center, he was a researcher at the Moffitt Cancer Center in Tampa, Florida, for seven years.

Daud has won numerous awards, including a Young Investigator Award from the American Society of Clinical Oncology and selection as a Castle Connolly Top Doctor.

  • Education

    Government Medical College, Nagpur, 1986

  • Residencies

    Indiana University School of Medicine, 1997

  • Fellowships

    Memorial Sloan-Kettering Cancer Center, 2000

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

    Internal Medicine, American Board of Internal Medicine

  • Academic Title


  • Languages


The future of cancer therapy is here, and it is immunotherapy. And it arrived a lot sooner than expected!

Clinics I work with

Melanoma & Skin Cancer Program

Bakar Precision Cancer Medicine Building

1825 Fourth Street, Third Floor
San Francisco, CA 94158

My reviews


Overall Experience
281 Reviews
Dr Daud has been the best doctor we've ever experienced in every way. We feel incredibly blessed to have him as our doctor.
Explained things in a way that was easy to understand
281 Reviews
Did the doctor pay attention to your concerns
281 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
264 Reviews
Knew the important information about your medical history
278 Reviews
The provider showed respect for what you had to say
280 Reviews
The provider spent enough time with me
279 Reviews

Selected research

Decorative Caduceus

A Study to Evaluate The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Vers...


Decorative Caduceus

Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Tr...

ORR defined as the proportion of patients with a best overall response of either confirmed complete response or confirmed partial response (as per local review and according to RECIST v1.1)


Decorative Caduceus

A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma


Decorative Caduceus

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Treatment-related adverse events as assessed by CTCAE v4.03